SCHEMBL8924522

SCHEMBL8924522

Cc1ccc(C2CCC(=NO)c3ccccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP19A1 P11511 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
PRCP P42785 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
HSD17B10 Q99714 1/20 0.33
ADCY5 O95622 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8924511 1.00 HPGD (0.38) HPGDL3MBTL1CYP19A1SMN1; SMN2PRCP
SCHEMBL8921189 0.85 HTT (0.40) HPGDL3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL8398673 0.85 SLC6A2 (0.38) HPGDCYP19A1SMN1; SMN2KDM4ENPC1
SCHEMBL8921192 0.85 HTT (0.40) HPGDL3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL8920191 0.85 HPGD (0.38) HPGDL3MBTL1CYP19A1SMN1; SMN2PRCP
SCHEMBL8920189 0.85 HPGD (0.38) HPGDL3MBTL1CYP19A1SMN1; SMN2PRCP
SCHEMBL8403202 0.83 SLC6A2 (0.41) CYP19A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL8403204 0.83 SLC6A2 (0.41) CYP19A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL8399422 0.83 SLC6A2 (0.41) CYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL8399423 0.83 SLC6A2 (0.41) CYP19A1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643904-A Substituted hexahdryoazepinones and tetrahydrobenzazepinones PFIZER INC. (US) 1997-07-01 US disclosed
US-5484917-A FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL DISORDERS, PAIN AND ANXIETY PFIZER INC. (US) 1996-01-16 US disclosed
EP-0625145-A1 3-PHENYLUREIDO-AZEPIN-2-ONES AND -BENZAZEPIN-2-ONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS PFIZER INC. (US) 1994-11-23 EP disclosed
WO-1993015059-A1 3-PHENYLUREIDO-AZEPIN-2-ONES AND -BENZAZEPIN-2-ONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS PFIZER INC. (US) 1993-08-05 WO disclosed